Opening opportunities for Kd determination and screening of MHC peptide complexes

Commun Biol. 2022 May 23;5(1):488. doi: 10.1038/s42003-022-03366-0.

Abstract

An essential element of adaptive immunity is selective binding of peptide antigens by major histocompatibility complex (MHC) class I proteins and their presentation to cytotoxic T lymphocytes. Using native mass spectrometry, we analyze the binding of peptides to an empty disulfide-stabilized HLA-A*02:01 molecule and, due to its unique stability, we determine binding affinities of complexes loaded with truncated or charge-reduced peptides. We find that the two anchor positions can be stabilized independently, and we further analyze the contribution of additional amino acid positions to the binding strength. As a complement to computational prediction tools, our method estimates binding strength of even low-affinity peptides to MHC class I complexes quickly and efficiently. It has huge potential to eliminate binding affinity biases and thus accelerate drug discovery in infectious diseases, autoimmunity, vaccine design, and cancer immunotherapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • HLA Antigens
  • Histocompatibility Antigens Class I*
  • Peptides* / chemistry
  • T-Lymphocytes, Cytotoxic

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class I
  • Peptides